The European LeukemiaNet is an EU-funded organisation of physicians, scientists and patients with interest in leukemia.
It aims to improve the treatment and knowledge about Leukemia in Europe and spread excellence. The website delivers
information for physicians, patients (e.g. patient organisations in Europe), ongoing clinical trials and
further information about the disease. You can get information about the European LeukemiaNet in
various european languages. The European LeukemiaNet is
funded by the 6th Framework Program of the European Community.
The most visible results of the ELN are the guidelines and management recommendations for virtually every leukemia and interdisciplinary speciality which have lain the groundwork for uniform definitions and standards required for common clinical trials and projects.
From July 2010 to June 2015, the European LeukemiaNet is funded through a research networking programme initiated by the ESF. The mid-term report summarizing ELN’s activities of the past three years was recently submitted to the ESF.
194 Participating Centers in 39 Countries (1000 Researchers and Associates) are cooperating in the European Leukemia Net. The objective is to integrate the 108 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 105 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care (data updated July 2013).